CAMP4 Therapeutics Corpor...

AI Score

XX

Unlock

1.84
0.06 (3.37%)
At close: Apr 15, 2025, 3:59 PM
1.85
0.44%
After-hours: Apr 15, 2025, 05:48 PM EDT

Company Description

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients.

The company was founded by Richard A.

Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corporation logo
Country United States
IPO Date Oct 11, 2024
Industry Biotechnology
Sector Healthcare
Employees 55
CEO Joshua Mandel-Brehm

Contact Details

Address:
One Kendall Square Bldg 1400 West, 3rd Floor
Cambridge, Massachusetts
United States
Website https://www.camp4tx.com/

Stock Details

Ticker Symbol CAMP
Exchange NASDAQ
Fiscal Year March - February
Reporting Currency USD
CIK Code 0000730255
CUSIP Number 13463J101
ISIN Number US13463J1016
Employer ID 95-3647070
SIC Code 3663

Key Executives

Name Position
Joshua Mandel-Brehm Chief Executive Officer, President & Director
Kelly Gold Chief Financial Officer
Michelle Gates Senior Vice President & Chief People Officer
Caleb Moore Chief Business Operations Officer & SVice President of Portfolio Strategy & Business Operations
Dr. Daniel Tardiff Ph.D. Vice President & Head of Discovery
Dr. David Bumcrot Ph.D. Chief Scientific Officer & Senior Vice President of Research
Dr. Leonard I. Zon M.D. Founder
Dr. Richard A. Young Ph.D. Founder & Independent Director
Dr. Satya Kuchimanchi Ph.D. Senior Vice President of Technical Operations
Dr. Yuri Maricich M.B.A., M.D. Chief Medical Officer

Latest SEC Filings

Date Type Title
Apr 11, 2025 3/A [Amend] Filing
Apr 03, 2025 4 Filing
Apr 03, 2025 4 Filing
Apr 03, 2025 4 Filing
Apr 03, 2025 4 Filing
Mar 27, 2025 S-8 Filing
Mar 27, 2025 10-K Annual Report
Mar 27, 2025 8-K Current Report
Mar 19, 2025 4 Filing
Mar 19, 2025 4 Filing